Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc.verified

CKPT

Price:

$3.75

Market Cap:

$180.50M

Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302, a human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells. It is also developing Olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a tre...[Read more]

Industry

Biotechnology

IPO Date

2016-12-19

Stock Exchange

NASDAQ

Ticker

CKPT

The Dividend Yield as of November 2024 (TTM) for Checkpoint Therapeutics, Inc. (CKPT) is 0%

According to Checkpoint Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Checkpoint Therapeutics, Inc. (CKPT) Historical Dividend Yield (quarterly & annually)

How has CKPT Dividend Yield performed in the past?

The mean historical Dividend Yield of Checkpoint Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CKPT's Dividend Yield was at its highest in in the March 2015 quarter at 0%. The Dividend Yield was at its lowest in in the March 2015 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Checkpoint Therapeutics, Inc. (CKPT) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Checkpoint Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%

Checkpoint Therapeutics, Inc. (CKPT) Average Dividend Yield

How has CKPT Dividend Yield performed in the past?

The current Dividend Yield of Checkpoint Therapeutics, Inc. (CKPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Checkpoint Therapeutics, Inc. (CKPT) Dividend Yield vs. Peers

How is CKPT’s Dividend Yield compared to its peers?

Checkpoint Therapeutics, Inc.’s Dividend Yield is less than Mustang Bio, Inc. (0%), less than Reviva Pharmaceuticals Holdings, Inc. (0%), less than Fortress Biotech, Inc. (0%), less than Kodiak Sciences Inc. (0%), less than Fortress Biotech, Inc. (0%), less than Avenue Therapeutics, Inc. (0%), less than Pieris Pharmaceuticals, Inc. (0%), less than Aileron Therapeutics, Inc. (0%), less than CytomX Therapeutics, Inc. (0%), less than Instil Bio, Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Assembly Biosciences, Inc. (0%), less than Achilles Therapeutics plc (0%), less than Cue Biopharma, Inc. (0%), less than Medicenna Therapeutics Corp. (0%), less than XOMA Corporation (1.55%), less than ZIVO Bioscience, Inc. (0%), less than Lumos Pharma, Inc. (0%),

Build a custom stock screener for Checkpoint Therapeutics, Inc. (CKPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Checkpoint Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Checkpoint Therapeutics, Inc. (CKPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Checkpoint Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Checkpoint Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Checkpoint Therapeutics, Inc. (CKPT)?

What is the highest Dividend Yield for Checkpoint Therapeutics, Inc. (CKPT)?

What is the 3-year average Dividend Yield for Checkpoint Therapeutics, Inc. (CKPT)?

What is the 5-year average Dividend Yield for Checkpoint Therapeutics, Inc. (CKPT)?

How does the current Dividend Yield for Checkpoint Therapeutics, Inc. (CKPT) compare to its historical average?